Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Roger's 1998 Short Picks -- Ignore unavailable to you. Want to Upgrade?

To: vegetarian who wrote (1957)	1/30/1998 10:57:00 AM
From: Dante Sinferno	Read Replies (1) \| Respond to of 18691

NOX Convertible..... Novavax Announces $6.5 Million Private Placement COLUMBIA, Md., Jan. 30 /PRNewswire/ -- Novavax, Inc. (Amex: NOX) announced the closing of a private placement of $6.5 million in custom convertible preferred stock. Novavax plans to use the proceeds of the private placement for general purposes, including clinical development and development of existing and emerging technology platforms. The preferred stock is convertible into common stock of the Company, subject to certain limitations, at 100% of a market price formula for the first 90 days and at 94% thereafter. The conversion price is subject to minimums and a maximum over certain periods of time. The preferred stock yields five percent per annum, payable in common stock at the time of conversion. The Company can, at its option, call any unconverted preferred stock at the end of two and three years at certain agreed upon prices. The holders have the option to put the preferred stock back to the Company upon the occurrence of certain specified events. Novavax has agreed to file a registration statement for the resale of shares acquired upon conversion of the convertible preferred stock. Brenda L. Fugagli, Vice President, Chief Financial Officer, said, "This financing enhances our current cash balances and allows Novavax the opportunity to further develop its expanding clinical and preclinical programs while accelerating the growth of our underlying infrastructure. Additionally, this financing provides an innovative structure which we believed to be a stronger financing opportunity than a secondary offering at this time." Richard F. Maradie, President and Chief Executive Officer, added, "It allows us to focus on securing strong strategic alliances, further building the existing value of our technology assets." Diaz & Altschul Capital, LLC of New York City was the placement agent in the transaction. Delta Opportunity Fund, Ltd., which is advised by Diaz & Altschul Advisors, LLC, is the lead investor in the transaction. The Company currently has three product candidates in human clinical testing. ESTRASORB(TM), a topical estrogen replacement cream for menopausal and post menopausal women, ANDROSORB(TM), a topical testosterone cream for testosterone deficient men and Helicore(TM) an oral antibacterial preparation developed to eradicate Helicobacter pylori bacteria, the principal cause of peptic ulcers and various gastric disorders. Novavax, Inc. is a bio-pharmaceutical drug delivery company. This press release may contain forward-looking information and should be read in conjunction with Exhibit 99 to the Company's Form 10-K for the year ended December 31, 1996, which is incorporated herein by reference. Statements made in this press release that state the Company's or management's intentions, hopes, beliefs, expectations or predictions of the future are forward-looking statements. It is important to note that the Company's actual results could differ materially from those projected in such forward-looking statements. Rob

To: vegetarian who wrote (1957)	2/1/1998 4:09:00 PM
From: posthumousone	Read Replies (1) \| Respond to of 18691

hey MC thx i am learnign alot from this thread this is a neat site suretrade.stkwtch.com For TA COMMENT Moving Average Convergence/Divergence (MACD) indicates a BEARISH TREND Chart pattern indicates a WEAK DOWNWARD TREND Relative Strength is BEARISH Up/Down volume pattern indicates that the stock is under DISTRIBUTION The 50 day MOVING AVERAGE is falling which is BEARISH The 200 day MOVING AVERAGE is rising which is BULLISH LOOK FOR SUPPORT AT 12.45 WATCH FOR RESISTANCE AT 13.88 RECOMMENDATION STOCK IS A SHORT CANDIDATE IF YOU ARE LONG; CLOSE POSITION OR MONITOR STOCK CLOSELY <<The company is producing $5M MTA architecture computers>> im not sure where you go t htis # the machine going to SD willrevenue 3.9M but they are palnign to sell ,, at first, 16 processor machines for 12M a piece......Salomon report forecasted 4 machines being sold this year <<How are you playing this one?>>> well this ppast year was a real learnign experience for me........first year in stocks.....just turned 30 so was doing mutual funds....got cocky thinking this is easy to make money.......think ive done every begineer misstake around..........with TERA a had 10k warrants when they called them early in june.....YIKES.....i really had no idea what to do......i looked for similiar early redemptions and saw that price generally went down so i bailed and lost alot!!!!!! luckily i was following this very closely adn jumped back in when slaomn issued report so i was able to ride it up adn make ti back and more.....still made many mistakes.....held on too long with hope that they were going to announce somehting big instead of reading charts.......EMOTIONALLY atached to stock for sure........did sell of over 14 buy back around 12, but soon as i sold my hands would get sweaty....oh gosh, now there going to deliever and i'll miss the boat.....i hung on in DEC when price was 17 becuase of tax reasons....not thinking to clearly again........sold part the 31st 15 3/8 adn the rest of the lots 15 1/4 on 2nd jan........i read a great book trading for a living that made me realize what a loser i had been as far as some of my decisions...it helped remove myself from stock adn be more logical (im an engineer dammit..im not supposed to be emotional : ) ---------- am i going to short......not yet, to much to learn adn to much i dont understand.........i placed questions on Yahoo board concerning placement but people didnt respond....as if its no big deal.........i am using this a learnign experience right now, lucky to be ahead .kinda sitting on sidelines.......figure with market as volatile as it is its a good idea to take break for a month